Format

Send to

Choose Destination
Infect Dis (Lond). 2018 May;50(5):388-390. doi: 10.1080/23744235.2017.1404632. Epub 2017 Dec 1.

Association between anti-tuberculosis drug resistance-conferring mutations and treatment outcomes in Myanmar.

Author information

1
a Department of Microbiology and Immunology, School of Biomedical Sciences , University of Otago , Dunedin , New Zealand.
2
b National Health Laboratory , Ministry of Health and Sports , Yangon , Myanmar.
3
c National Tuberculosis Reference Laboratory , Ministry of Health and Sports , Yangon , Myanmar.
4
d Massey Genome Service , Institute of Fundamental Science, Massey University , Palmerston North , New Zealand.
5
e Centre for International Health, Dunedin School of Medicine , University of Otago , Dunedin , New Zealand.
6
f Department of Microbiology , University of Medicine 1 , Yangon , Myanmar.
7
g National Tuberculosis Programme, Ministry of Health and Sports , Naypyitaw , Myanmar.
PMID:
29192532
DOI:
10.1080/23744235.2017.1404632
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center